title: Discontinued drugs in 2006: oncology drugs.
abstract: This perspective is the last in a series of papers discussing drugs dropped from clinical development in 2006. Specifically, this paper focuses on the 16 drugs discontinued for the treatment of cancer, the largest area of pharma R&D. This was based on a search of the Pharmaprojects database for drugs reaching Phase I-III clinical trials.
authors.affiliation: Drug Development Office, Cancer Research UK, 61 Lincoln's Inn Fields, London WC2A 3PX, UK. Robert.williams@cancer.org.uk
authors.forename: Robert
authors.initials: R
authors.lastname: Williams
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D015507:Drugs, Investigational / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational